Abacavir is a widely used nucleotide reverse transcriptase inhibitor whose cerebrospinal fluid (CSF) exposure has been previously assessed in twice-daily recipients. We studied abacavir CSF concentrations in 61 and 9 HIV-positive once-daily and twice-daily abacavir intakers. Patients on once-daily abacavir had higher plasma and CSF concentrations (96 vs. 22 ng/mL, p=0.038 and 123 vs. 49 ng/mL, p=0.038) but similar CSF-to-plasma ratios (0.8 vs. 0.5, p=0.500). CSF abacavir concentrations were adequate in once-daily receiving patients.
Cerebrospinal Fluid Abacavir Concentrations in HIV-positive Patients Following Once-daily Administration
Calcagno, A
First
;De Nicolò, A;D'Avolio Antonio;Di Perri, G;Bonora, S
Last
2018-01-01
Abstract
Abacavir is a widely used nucleotide reverse transcriptase inhibitor whose cerebrospinal fluid (CSF) exposure has been previously assessed in twice-daily recipients. We studied abacavir CSF concentrations in 61 and 9 HIV-positive once-daily and twice-daily abacavir intakers. Patients on once-daily abacavir had higher plasma and CSF concentrations (96 vs. 22 ng/mL, p=0.038 and 123 vs. 49 ng/mL, p=0.038) but similar CSF-to-plasma ratios (0.8 vs. 0.5, p=0.500). CSF abacavir concentrations were adequate in once-daily receiving patients.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
CSF ABC once daily BJCP 2018.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
282.85 kB
Formato
Adobe PDF
|
282.85 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
CSFABC_shortreportR1_5feb2018_nofig_FINAL.docx
Accesso riservato
Tipo di file:
POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione
43.25 kB
Formato
Microsoft Word XML
|
43.25 kB | Microsoft Word XML | Visualizza/Apri Richiedi una copia |
CSFABC_shortreportR1_5feb2018_nofig_FINAL.pdf
Accesso aperto
Tipo di file:
POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione
69.26 kB
Formato
Adobe PDF
|
69.26 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.